Total-Body PET scanner pushed to its limits in tiny cancer study
NCT ID NCT05160480
First seen Jan 31, 2026 · Last updated May 15, 2026 · Updated 11 times
Summary
This study aims to improve how total-body PET scans work for people with prostate cancer, breast cancer, or neuroendocrine tumors. Researchers will collect extra data from FDA-approved imaging agents during routine scans. Only 9 participants are needed, and the goal is to learn more about how these scans can better detect and measure cancer throughout the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UC Davis EXPLORER Molecular Imaging Center
Sacramento, California, 95816, United States
Conditions
Explore the condition pages connected to this study.